Device General - Structural Heart_ic

General - Structural Heart

Payments companies reported to CMS as associated with General - Structural Heart. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$494Kassociated payments (2023-2025)
371clinicians with associated payments
1company reporting

By year

2025 $494K

Payments reported as associated with General - Structural Heart, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $197K
Interventional Cardiology $160K
Advanced Heart Failure and Transplant Cardiology $13K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $13K
Clinical Cardiac Electrophysiology $4,258
Acute Care (Nurse Practitioner) $3,138

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with General - Structural Heart

These are the largest totals companies reported as associated with General - Structural Heart. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rafey Feroze Cleveland, OH $50,000.00
Pradnya Brijmohan Bhattad Minneapolis, MN Cardiovascular Disease $30,000.00
Ashwini Kerkar Ann Arbor, MI Cardiovascular Disease $25,000.00
Moshrik Abd-Alamir Toledo, OH Cardiovascular Disease $25,000.00
Shannon Clay Minneapolis, MN $25,000.00
Andrea Soares Sacramento, CA Cardiovascular Disease $25,000.00
Michael Rinaldi Charlotte, NC Cardiovascular Disease $20,721.08
Akshay Kamath Albany, NY Interventional Cardiology $20,000.00
Kamran Ali Birmingham, AL Interventional Cardiology $15,000.00
Lauren Ranard New York, NY Interventional Cardiology $15,000.00

Prescribed General - Structural Heart?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.